Showing results (521-530 of 833) with videos related to

Sort By:
Pageof 84
AIDS (London, England)|November 24, 1999
Regional survival differences across Europe in HIV-positive people: the EuroSIDA studyA Chiesi, A Mocroft, L G Dally, et al.
Epidemiology and Infection|November 1, 2000
Regional differences in presentation of AIDS in EuropeA Blaxhult, O Kirk, C Pedersen, et al.
The Journal of Infectious Diseases|March 23, 2001
Influence of age on CD4 cell recovery in human immunodeficiency virus-infected patients receiving highly active antiretroviral therapy: evidence from the EuroSIDA studyJ P Viard, A Mocroft, A Chiesi, et al.
HIV Medicine|December 12, 2001
Does European or non-European origin influence health care and prognosis for HIV patients in Europe? The EuroSIDA Study GroupA Blaxhult, A Mocroft, A Phillips, et al.
AIDS (London, England)|November 15, 2005
Is there evidence for an increase in the death rate from liver-related disease in patients with HIV?Amanda Mocroft, Vincent Soriano, Jurgen Rockstroh, et al.
Scandinavian Journal of Infectious Diseases|July 9, 2008
Fungal infection as a risk factor for HIV disease progression among patients with a CD4 count above 200/microl in the era of cARTDaria Podlekareva, Amanda Mocroft, Ole Kirk, et al.
The Journal of Infectious Diseases|August 15, 2009
Activation and coagulation biomarkers are independent predictors of the development of opportunistic disease in patients with HIV infectionAlison J Rodger, Zoe Fox, Jens D Lundgren, et al.
AIDS (London, England)|May 13, 2006
Relationship between antiretrovirals used as part of a cART regimen and CD4 cell count increases in patients with suppressed viremiaAmanda Mocroft, Andrew N Phillips, Bruno Ledergerber, et al.
Antiviral Therapy|April 26, 2013
Further research needed to support a policy of antiretroviral therapy as an HIV prevention initiativeAlison J Rodger, Tina Bruun, Pietro Vernazza, et al.
AIDS (London, England)|December 12, 2001
Viral load outcome of non-nucleoside reverse transcriptase inhibitor regimens for 2203 mainly antiretroviral-experienced patientsA N Phillips, C Pradier, A Lazzarin, et al.
Pageof 84